Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Cash & Current Investments: 2022-2025

Historic Cash & Current Investments for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $892.4 million.

  • Immunocore Holdings' Cash & Current Investments fell 0.99% to $892.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 13.05%. This contributed to the annual value of $820.4 million for FY2024, which is 85.34% up from last year.
  • Latest data reveals that Immunocore Holdings reported Cash & Current Investments of $892.4 million as of Q3 2025, which was up 1.08% from $882.8 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Cash & Current Investments high stood at $901.3 million for Q3 2024, and its period low was $402.5 million during Q4 2022.
  • Over the past 3 years, Immunocore Holdings' median Cash & Current Investments value was $848.3 million (recorded in 2024), while the average stood at $808.6 million.
  • Per our database at Business Quant, Immunocore Holdings' Cash & Current Investments soared by 85.34% in 2024 and then decreased by 0.99% in 2025.
  • Immunocore Holdings' Cash & Current Investments (Quarterly) stood at $402.5 million in 2022, then increased by 9.98% to $442.6 million in 2023, then soared by 85.34% to $820.4 million in 2024, then declined by 0.99% to $892.4 million in 2025.
  • Its Cash & Current Investments stands at $892.4 million for Q3 2025, versus $882.8 million for Q2 2025 and $837.0 million for Q1 2025.